Replies to post #223703 on Biotech Values

[IanFromSI]

It doesn't make sense to me that a company that has > $5Bil turnover should be trading at less than 1/10 of sales.

The company has said its sales numbers are wrong, its rate of customer loss increased sharply in January.

While it's possible the market has overreacted to the news, it is an unknown at this point. even to dplo itself.

[DewDiligence]

DPLO -50% on “going concern” qualification in 10-Q:

https://www.sec.gov/ix?doc=/Archives/edgar/data/1610092/000155837019010799/dplo-20190930x10qfb31fe.htm

As noted in #msg-147049835, “Not filing timely SEC reports warrants substantial bearishness…”